Comprehensive analysis of clinical indications and viral strain variants among patients infected with SARS-CoV-2 in Inner Mongolia, China

[1]  Hebleen Brenes,et al.  Clinical Profiles at the Time of Diagnosis of SARS-CoV-2 Infection in Costa Rica During the Pre-vaccination Period Using a Machine Learning Approach , 2022, Phenomics.

[2]  Wan Yang,et al.  COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination , 2022, Journal of the Royal Society Interface.

[3]  Mohammad Y. Alshahrani,et al.  Association of disease severity and death outcome with vaccination status of admitted COVID-19 patients in delta period of SARS-COV-2 in mixed variety of vaccine background , 2022, Saudi Journal of Biological Sciences.

[4]  Vineet D. Menachery,et al.  Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2022, Cell Reports.

[5]  Madeeha Shahzad Lodhi,et al.  Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic , 2022, Genes.

[6]  H. Yassine,et al.  Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines , 2022, Annals of medicine.

[7]  S. Negi,et al.  Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India , 2022, Microbial Pathogenesis.

[8]  D. Parums.  Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19 , 2021, Medical science monitor : international medical journal of experimental and clinical research.

[9]  R. Lin,et al.  Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study , 2021, Clinical Microbiology and Infection.

[10]  Kang Zhang,et al.  COVID-19 Delta variants—Current status and implications as of August 2021 , 2021, Precision clinical medicine.

[11]  Xilong Deng,et al.  Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China , 2021, EClinicalMedicine.

[12]  Vineet D. Menachery,et al.  Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2021, bioRxiv.

[13]  Zijian Feng,et al.  Long Distance Transmission of SARS-CoV-2 from Contaminated Cold Chain Products to Humans — Qingdao City, Shandong Province, China, September 2020 , 2021, China CDC weekly.

[14]  A. Vitiello,et al.  COVID-19 vaccines and decreased transmission of SARS-CoV-2 , 2021, Inflammopharmacology.

[15]  Lanjuan Li,et al.  Preliminary Assessment of Chinese Strategy in Controlling Reemergent Local Outbreak of COVID-19 , 2021, Frontiers in Public Health.

[16]  J. Zahradník,et al.  SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity , 2021, Cell Host & Microbe.

[17]  S. Jahanfar,et al.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review , 2021, European Journal of Medical Research.

[18]  H. Jinno,et al.  A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis. , 2021, The Journal of toxicological sciences.

[19]  M. Trauner,et al.  Pathophysiological mechanisms of liver injury in COVID‐19 , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[20]  B. Salzberger,et al.  Epidemiology of SARS-CoV-2 , 2020, Infection.

[21]  Ralf Bartenschlager,et al.  Structures and distributions of SARS-CoV-2 spike proteins on intact virions , 2020, Nature.

[22]  Liqing Cheng,et al.  Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis , 2020, Aging.

[23]  B. Lina,et al.  Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation , 2020, bioRxiv.

[24]  R. Venugopal,et al.  COVID-19 and the liver , 2020, Journal of Hepatology.

[25]  R. L. Harrison,et al.  The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks , 2020, Nature Microbiology.

[26]  Lei Liu,et al.  COVID-19: Abnormal liver function tests , 2020, Journal of Hepatology.

[27]  Changsheng Zhang,et al.  Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites , 2020, bioRxiv.

[28]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[29]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[30]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[31]  C. Ke,et al.  Serum cytokines and clinical features in patients with fever and thrombocytopenia syndrome , 2019, Clinica Chimica Acta.

[32]  Adam M. Phillippy,et al.  MUMmer4: A fast and versatile genome alignment system , 2018, PLoS Comput. Biol..